Are there any science policy blogs that focus on synthetic biology regulation, funding, and commercial impact?

Yes — there are a few good places to follow synthetic biology policy specifically, though the coverage is often split across broader science policy, biosecurity, biotech regulation, and innovation/commercialization blogs.

Here are some useful options:

Synthetic bio / biotech policy and regulation

• The SynBioBeta blog
  Covers synthetic biology business, regulation, commercialization, and industry trends. Good for the “commercial impact” angle.

• iGEM’s policy and practices materials / blog content
  Not a classic policy blog, but they often discuss governance, safety, and public policy issues around synthetic biology.

• EU/US biotech and life sciences policy blogs
  These aren’t synthetic-bio-only, but they frequently cover gene editing, engineered organisms, and regulatory frameworks that affect synbio companies.

Broader science policy blogs that often touch synbio

• The Scholarly Kitchen
  More about publishing and research policy, but sometimes relevant for funding and innovation ecosystems.

• Science | AAAS policy coverage and blogs
  Strong on federal funding, regulation, and biotech policy developments.

• The Incidental Economist
  Mostly health policy, but can be relevant when synbio intersects with medicine, reimbursement, and commercialization.

• Brookings science/technology policy pieces
  Often covers governance, innovation policy, and regulatory implications for emerging biotech.

Biosecurity / governance blogs

These are especially useful if you care about regulation and oversight:

• The Bulletin of the Atomic Scientists
• Biosafety and Biosecurity–focused centers and blogs
• Center for Health Security (Johns Hopkins)
  Sometimes covers synthetic biology governance, risk, and policy.

Funding / innovation / commercialization

For the funding and market side, look at:

• Endpoints News
• STAT
• Fierce Biotech
• Nature Biotechnology news/blog coverage
• Biospace

These are not policy blogs per se, but they often discuss regulatory changes, funding rounds, and market impact for synthetic biology firms.

Best way to track this niche

Because no single blog dominates the whole space, many people follow a mix of:

1. industry blogs for commercialization,
2. science policy outlets for regulation/funding,
3. biosecurity/governance groups for oversight issues.

If you want, I can also give you:

• a short curated list of the best 5,
• academic/policy blogs only, or
• a list organized by US / EU / global regulation.